Companies · Healthtech

Health Intelligence Co Llc

CHICAGO · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Health Intelligence Co Llc — recommendation, valuation, rhythm, risks.
$70.6M
Total raised · real
2
Rounds
1.2×
Latest step-up
Top 7%
Sector rank · raised
Series C
Latest stage · inferred · Thu Apr 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time)

Health Intelligence Co Llc has raised $71M over 2 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Dormant
  • Last raise 14.2 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Health Intelligence Co Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
15.5 yr record
Peak capital year was 2012 with $214.2M across 6 filings.
Market position
ahead of 94% of Healthtech peers
Capital scale is ahead of 94% of Healthtech peers; modeled value is above 97% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2012: $214.2M across 6 filings.
  • Largest single filing was $42.6M on 2012-04-05.
  • Filing rows sum to $242.2M, while canonical raised total is $70.6M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Health Intelligence Co Llc is one of 2138 Healthtech companies tracked from CHICAGO. By capital raised it ranks among the largest (ahead of 94% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
19
Investors (latest)
2012-04-05
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeries B · 2010-12-17 Raised $28M (real) Modeled valuation $694M (est)Series B2010Series C · 2012-04-05 Raised $43M (real) Modeled valuation $1.1B (est)Series C2012Series C · 2012-04-05 Raised $43M (real) Modeled valuation $1.1B (est)Series C2012Series C · 2012-04-05 Raised $43M (real) Modeled valuation $1.1B (est)Series C2012Series A · 2012-04-05 Raised $9.4M (real) Modeled valuation $212M (est)Series A2012Series B · 2012-04-05 Raised $35M (real) Modeled valuation $856M (est)Series B2012Series C · 2012-04-05 Raised $43M (real) Modeled valuation $1.1B (est)Series C2012+$43M+$43M+$43M+$9.4M+$35M+$43MCumulative $242M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$28.0M · 2010
Series C$42.6M · 2012
Series C extension$42.6M · 2012
Series C extension$42.6M · 2012
Bridge · Series C-stage$9.4M · 2012smaller follow-on
Bridge · Series C-stage$34.5M · 2012smaller follow-on
Series C extension$42.6M · 2012

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 60%.

Modeled valuation trajectory
$1.1B
Base estimate est.
$154.7M
Conservative case
$2.9B
Upside case
$283.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series B · modeled $694.1M · 2010-12-172010Series C · modeled $1.1B · 2012-04-05Series C · modeled $1.1B · 2012-04-05Series C · modeled $1.1B · 2012-04-05Series A · modeled $212.0M · 2012-04-05Series B · modeled $856.0M · 2012-04-05Series C · modeled $1.1B · 2012-04-052012
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.32×/yr
Annual markup
1.51×/yr upside case
6.0 yr
Elapsed time used
14.2 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
3 mo
Avg between rounds
$54.3M/yr
Capital velocity
15.5 yr
On record since
2010
First round
7
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 16× above median
This company$70.6M
Sector median$4.5M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.9× of median
This company$42.6M
Sector median$46.5M
Modeled value — vs sector median (estimate, all stages) 32× above median
This company$1.1B
Sector median$33.8M

Raised more than 94% of sector peers (real $). Modeled value above 97% of peers (estimate).

Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$28.0M2010-12-17$155.6M$694.1M85%
Series C$42.6M2012-04-05$283.7M$1.1B90%
Series C$42.6M2012-04-05$283.7M$1.1B85%
Series C$42.6M2012-04-05$283.7M$1.1B85%
Series A$9.4M2012-04-05$42.7M$212.0M85%
Series B$34.5M2012-04-05$191.9M$856.0M85%
Series C$42.6M2012-04-05$283.7M$1.1B85%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$28.0M2010-12-17
    • First recorded raise — entered as Series B.
    • 20 investors on this round.
  2. Series C$42.6M2012-04-05
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 19 investors on this round.
  3. Series C$42.6M2012-04-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 19 investors on this round.
  4. Series C$42.6M2012-04-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 19 investors on this round.
  5. Series A$9.4M2012-04-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 4.5× smaller than the prior — bridge or down round.
    • Switched to Rule 06 (was Rule 506(b)).
    • 15 investors on this round.
  6. Series B$34.5M2012-04-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.7× larger than the prior — scaling up.
    • 18 investors on this round.
  7. Series C$42.6M2012-04-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • Switched to Rule 506(b) (was Rule 06).
    • 19 investors on this round.
Intelligence
2012 ~Q2
Modeled next raise · ~3mo cadence
$52.4M
Modeled next size est.range $42.6M$83.9M
1.2×
Last step-up
$54.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
SWATI ABBOTT2 other2012-04
DOUG PORTER1 other2010-12
ROGER WILSON1 other2010-12
SCOTT SEROTA1 other2012-04
STEVEN MARTIN1 other2012-04
ALLEN D. MALTZ2012-04
ALLEN R. MALTZ2012-04
ARNOLD DUKE LIVERMORE II2010-12
BOB KOLODGY2010-12
BRIAN DUKE HEDBERG2010-12
BRIAN HEDBERG2012-04
BRIAN R. HEDBERG2012-04
BRIAN S. HEDBERG2012-04
CHARLES ALLISON2012-04
DARREN H. ROGERS2012-04
DARREN RODGERS2012-04
DAVID H. KING2012-04
DEBORAH D. RICE-JOHNSON2012-04
DONALD R. FISCHER2012-04
DONALD R. FISCHER, M.D.2010-12
DR. THOMAS MARK HAWKINS2010-12
Garret Hargrave2012-04
JACQUELINE H. STUDER2012-04
JAMES D. BAILEY2012-04
Registry & provenance

Health Intelligence Co Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1508432
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Prognos Health Inc.HealthtechSeries B$63.4M$235.2Mnetwork1 shared operator · same sector
Stellar Health Group, Inc.HealthtechSeries C$71.1M$1.1Bsame sector · same stage
Fresenius Medical Care Voorhees, LLCHealthtechSeries C$71.1M$1.8Bsame sector · same stage
Brightside Health, Inc.HealthtechSeries C$69.9M$800.8Msame sector · same stage
Ophelia Health, Inc.HealthtechSeries C$68.4M$859.9Msame sector · same stage
Diverge Health, Inc.HealthtechSeries C$68.2M$407.8Msame sector · same stage
Eden Health, Inc.HealthtechSeries C$73.4M$1.3Bsame sector · same stage
Clarify Medical, Inc.HealthtechSeries C$67.6M$776.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Healtheo360 LLCHealthtechSeed$6.7M88%
Intelicare Health Services, LlcHealthtechSeed$25.0M88%
WELL Health Technologies Corp.HealthtechSeed$92.8M88%
Innovative Health LlcHealthtechSeries A$112.9M87%
Medical Monitoring Holdings, LLCHealthtechSeries A$17.6M87%
What About Health, Inc.HealthtechPre-Seed$7.6M87%
HealthEC, LLCHealthtechSeries A$33.3M87%
Health Care Solutions Inc.HealthtechSeed$26.8M87%
Frequently asked
How much funding has Health Intelligence Co Llc raised?
Health Intelligence Co Llc has raised approximately $70.6M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Health Intelligence Co Llc's estimated valuation?
Provath's modeled valuation for Health Intelligence Co Llc is approximately $1.1B (modeled range $154.7M–$2.9B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Health Intelligence Co Llc at?
Health Intelligence Co Llc's latest modeled financing stage is Series C. Its most recent recorded round closed around Thu Apr 05.
What does Health Intelligence Co Llc do and where is it based?
Health Intelligence Co Llc operates in the Healthtech sector, based in CHICAGO.
Explore related

See where Health Intelligence Co Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Health Intelligence Co Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.